← Eichor
Condition: High Risk Pregnancy Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: High Risk Pregnancy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Renal Adjuvant MultiPle Arm Randomised Trial
Phase 3 · 35 location(s) · University College, London · NCT03288532
Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer
NA · 8 location(s) · Tianjin Medical University Second Hospital · NCT07180212
Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer
Phase 2 · 3 location(s) · Tianjin Medical University Second Hospital · NCT07475403
Nafamostat Efficacy in Phase 3 Registrational CRRT Study
NA · 10 location(s) · Talphera, Inc · NCT06150742
Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia
Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT04712851
Collection and Distribution of Biospecimens for Novel Research Uses
Phase N/A · 2 location(s) · iSpecimen Inc · NCT03848962
Single-Center Prospective Study to Investigate the Difference in the Incidence of Contrast-Induced Nephropathy in High-R
Phase 4 · 1 location(s) · CAMC Health System · NCT04279457
Feasibility of Remote eCTG Monitoring Home@Hospital in Complicated Pregnancies
NA · 1 location(s) · Maxima Medical Center · NCT06859177
Telehealth and Remote Blood Pressure
NA · 1 location(s) · Wake Forest University Health Sciences · NCT07356518
Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cance
Phase 2 · 1 location(s) · Bai-Rong Xia · NCT07125391
A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Alb
Phase 2 · 71 location(s) · AstraZeneca · NCT07222917
Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients
Phase 1 · 1 location(s) · Theolytics Limited · NCT07211659
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
Phase 1/Phase 2 · 13 location(s) · Exscientia AI Ltd., a wholly owned subsidiary of Recursion P · NCT05985655
MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
Phase 3 · 53 location(s) · Swiss GO Trial Group · NCT04111978
Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT06727617
TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients
NA · 1 location(s) · Zhejiang University · NCT07480785
CTSN Embolic Protection Trial
NA · 28 location(s) · Icahn School of Medicine at Mount Sinai · NCT06027788
A Study Of Moderately Hypo-Fractionated External-beam Radiotherapy With Concurrent Chemotherapy and High Dose Rate Brach
NA · 1 location(s) · Ain Shams University · NCT07343531
Does Urinary TIMP2 and IGFBP7 Can Identify High Risk Patients of Progression From Mild and Moderate to Severe Acute Kidn
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT03547414
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
NA · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07270666
Prognostic Value of Novel Biomarkers on Adverse Renal Outcomes in High-Risk Cardiac Surgery Patients
Phase N/A · 2 location(s) · Guowei Tu · NCT07418242
Effects of Replacing High Protein Foods in People With Chronic Kidney Disease
NA · 1 location(s) · Indiana University · NCT07105670
A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ov
Phase N/A · 1 location(s) · Peking University Third Hospital · NCT07532434
Endometrial Cancer Lymphadenectomy Trial
NA · 61 location(s) · Philipps University Marburg · NCT03438474
DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With H
Phase 2/Phase 3 · 27 location(s) · Cancer Research UK · NCT05770102
Study of the Relaxin Agonist R2R01 in Patients at High Risk for Cardiac Surgery Associated- Acute Kidney Injury
Phase 2 · 1 location(s) · River 2 Renal Corp. · NCT07625553
Advanced Wireless Sensors for Neonatal Care in the Delivery Room
NA · 5 location(s) · Guilherme Sant'Anna, MD · NCT06693817
Remote Fetal Monitoring in High Risk Pregnancies
Phase N/A · 1 location(s) · Beth Israel Deaconess Medical Center · NCT06822439
T1D Pregnancy & Me
Phase N/A · 10 location(s) · Jaeb Center for Health Research · NCT06959316
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Beva
Phase 3 · 32 location(s) · Genelux Corporation · NCT05281471
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.